Discover investment opportunities in Canadian Pot Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Canadian Pot Stocks using our Smart AI Filter.
AI is processing your request...
Scanning thousands of stocks to find the best matches...
Discover investment opportunities in Canadian Pot Stocks using our Smart AI Filter.
6 stocks found for "Canadian Pot Stocks"
Security name | Expected returns | Sharpe Ratio | Beta | Volatility | P/E Ratio | Dividend Yield |
|---|---|---|---|---|---|---|
1.10 | ±44.1% | 16.2 | 3.89% | |||
0.86 | ±55.0% | 41.8 | 0.00% | |||
1.41 | ±67.6% | -20.4 | 0.00% | |||
1.42 | ±65.6% | -42.3 | 0.00% | |||
1.99 | ±100.0% | -1.7 | 0.00% | |||
1.43 | ±73.1% | -7.7 | 0.00% |
This search uses our Smart AI Filter to identify stocks matching your criteria. Results are ranked by relevance and include key financial metrics to help you make informed investment decisions.
Get personalized stock recommendations, save custom screens, and access premium filters. All our screening tools are free—signing up gives you more personalized results and the ability to save your research.
Compliance disclosure:
The securities listed on this website have not paid to be included in the results. The inclusion of any securities in the results shown does not imply any relationship with PortfolioPilot. The order of the results is ranked based on the Sharpe Ratio, which is a measure of risk-adjusted return. Please note that these listings are not recommendations or financial advice. Past performance is not indicative of future results.
Cannabis grower Organigram Holdings Inc. OGI reported third-quarter 2025 net sales of $51.14 million, approximately $70.8 million Canadian dollars (CAD), up 72% year-over-year, beating the consensus of $48.33 million.
Read moreCannabis stocks are rising after President Joe Biden publicly endorsed the Justice Department's recommendation to loosen restrictions on marijuana, reclassified from a Schedule I to a Schedule III drug. Poseidon Investment Management co-founder Emily Paxhia joins Market Domination to break down the news.
Read moreQ: What influences the performance of Canadian pot stocks like CGC, TLRY, and SNDL?
A: The performance of Canadian pot stocks such as CGC, TLRY, and SNDL is influenced by regulatory changes, market demand, production costs, and consumer trends in legality and acceptance of cannabis products. Additionally, these companies are impacted by international expansion opportunities and competition from other producers.
Q: How does the legalization trend in the U.S. affect Canadian pot stocks such as CGC and TLRY?
A: The legalization trend in the U.S. can affect Canadian pot stocks by expanding market opportunities but also increasing competition. Although Canadian companies are positioned to enter the U.S. market, they face challenges due to federal restrictions in the U.S. and the presence of established local players.
Q: What are the growth prospects for TLRY in the European cannabis market?
A: TLRY's growth prospects in the European market depend on the pace of legalization, partnerships, and the company's ability to navigate regulatory landscapes. Europe's fragmented regulations pose both challenges and opportunities for expansion.
Q: Do Canadian pot stocks like SNDL provide dividend income opportunities?
A: Generally, Canadian pot stocks like SNDL do not offer dividends as companies focus on reinvesting profits to expand operations. Investors seeking income should consider this aspect and analyze company financials for any future dividend declarations.
Q: What regulatory risks do CGC and SNDL face in Canada and globally?
A: CGC and SNDL face regulatory risks, including compliance with health regulations, product approvals, and international trade laws. Changes in regulations, enforcement in Canada, and barriers in international markets can impact operations.
Q: How do economic cycles influence the valuation of pot stocks like TLRY?
A: Pot stocks like TLRY are often subject to volatility due to economic cycles. In economic downturns, discretionary spending—including cannabis—may decline, affecting revenues. Conversely, robust economic growth can spur increased consumer spending.